Pfizer Eyes New Release with Once-A-Day Weight Loss Pill – Is it Safe?
With its new once-daily pill candidate, danuglipron, Pfizer is propelling a major change for the weight-loss medicine market. This medicine is a member of the exciting class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists, which have demonstrated success in controlling blood sugar levels and encouraging weight loss. Danuglipron seeks to offer those suffering with obesity, a disorder afflicting millions …